Work

Cardiologist Use of Sglt2 Inhibitors and Glp-1 Receptor Agonists Since Release of Favorable Cardiovascular Outcomes Trials: a National Study

Year: 2021

Type: article

Source: Journal of the American College of Cardiology

DOI: 10.1016/s0735-1097(21)02826-6

Authors: Rishav Adhikari, James Heyward, G. Caleb Alexander, Michael Blaha

Institution: Johns Hopkins University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3157971796

FWCI: 0.561

Cites:

Cited by: 4

Related to: 10